Jonas Van Audenaerde

11PUBLICATIONS
68CO-AUTHORS
NanomaterialsCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification.

|Mar 26, 2025
Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation.

Ruben Verloy, Angela Privat-Maldonado, Jonas Van Audenaerde

|Mar 27, 2023
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Tal Flieswasser, Astrid Van den Eynde, Laurie Freire Boullosa

|Nov 07, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.

Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme

|May 08, 2021
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.

Federico Virga, Federica Cappellesso, Benoit Stijlemans

|Mar 06, 2021
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.

Andreas Domen, Delphine Quatannens, Sara Zanivan

Pageof 2

Frequent Collaborators

6 joint publications

Evelien Smits

4 joint publications

Jorrit De Waele

3 joint publications

Elly Marcq

3 joint publications

Filip Lardon